We are 215,398 members in 81 forums discussing 153,221 topics.

Help with Abbreviations

Topic: Everything No One Tells You About Cancer and Your Sex Life

Forum: Sex & Relationship Matters —

A safe place to talk candidly about how your romantic relationships and/or your sex life has changed following your diagnosis and treatment.

Posted on: Nov 20, 2014 11:22AM - edited Jan 19, 2016 08:36AM by OneBadBoob

OneBadBoob wrote:

Everything . . .I found this booklet on line and wanted to share

updated link to this booklet

Jane - Dance as if no one is watching!! Dx 7/7/2007, IDC, <1cm, Stage I, Grade 1, 0/2 nodes, ER+/PR+, HER2-
Log in to post a reply

Page 9 of 9 (246 results)

Posts 241 - 246 (246 total)

Log in to post a reply

Feb 5, 2018 03:03PM Trvler wrote:

Kali: Thank you for saying that. You made my day! Good luck.

Allison Dx 1/16/2015, ILC, Left, 3cm, Stage IIB, Grade 2, ER+/PR+, HER2- Dx 2/26/2015, ILC, Left, 4cm, Stage IIIA, Grade 2, 2/2 nodes, ER+/PR+, HER2- Chemotherapy 3/24/2015 AC + T (Taxol) Surgery 9/1/2015 Mastectomy; Reconstruction (left): DIEP flap; Reconstruction (right): DIEP flap Radiation Therapy 10/15/2015 Whole-breast: Breast, Lymph nodes Hormonal Therapy 1/1/2016
Log in to post a reply

Mar 3, 2018 02:06PM norma6261 wrote:

I just had my first procedure done 3 days ago, fingers crossed

Log in to post a reply

Mar 3, 2018 02:23PM - edited Mar 3, 2018 02:24PM by norma6261

Mona Lisa touch. I just had my first procedure done 3 days ago, fingers crossed. Mona Lisa touch, Please help me!!!!

Log in to post a reply

Apr 11, 2018 07:41PM FLBuckeye93 wrote:

Just had my second Mona Lisa yesterday. The first one did make a difference so I’m encouraged.

My gyno also mentioned Intrarosa medication. I may add this in if Mona Lisa doesn’t fully work.

Dx 10/2015, DCIS/IDC, Left, 3cm, Stage IIA, Grade 2, 0/3 nodes, ER+/PR+, HER2- Hormonal Therapy 6/21/2016 Aromasin (exemestane) Dx 10/2016, LCIS, Right, 0/1 nodes Surgery 6/20/2017 Mastectomy: Left, Right; Reconstruction (left): SGAP flap/hip flap; Reconstruction (right): SGAP flap/hip flap Radiation Therapy Whole-breast: Breast, Lymph nodes Chemotherapy Cytoxan (cyclophosphamide), Taxotere (docetaxel) Surgery Lumpectomy: Left
Log in to post a reply

May 29, 2018 10:15PM Suz-Q wrote:

I just had my yearly exem with a new gyno. She said that I'm not a candidate for intrarosa because I'm on an aromitase inhibitor.

56 at diagnosis. Oncotype DX 10 Dx 9/17/2015, DCIS/IDC, Right, <1cm, Stage IA, Grade 2, 0/2 nodes, ER+/PR+, HER2- Surgery 11/2/2015 Lumpectomy: Right; Lymph node removal: Sentinel Radiation Therapy 12/13/2015 Whole-breast: Breast Hormonal Therapy 1/20/2016 Arimidex (anastrozole) Surgery 8/4/2016 Reconstruction (right): Fat grafting Hormonal Therapy 10/6/2017 Aromasin (exemestane)
Log in to post a reply

Jan 9, 2019 10:33PM macb04 wrote:

Hey Suz-Q,

They are actually doing a study on using Intrarosa while women are on AIs.

Effect of Intravaginal Prasterone on Symptoms of VVA in Women Under Treatment With an Aromatase Inhibitor for Breast Cancer The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.ClinicalTrials.gov Identifier: NCT03740945Recruitment Status : Not yet recruitingFirst Posted : November 14, 2018

Last Update Posted : November 14, 2018

See Contacts and Locations

Sponsor:

EndoCeutics Inc.

Collaborator:

AMAG Pharmaceuticals, Inc.

Information provided by (Responsible Party):

EndoCeutics Inc.

Study Description

Go to sections

Brief Summary:

The purpose of this study is to confirm the efficacy of intravaginal prasterone (DHEA) on moderate to severe (MS) and most bothersome symptoms (MBS) of vulvovaginal atrophy (VVA) due to natural, surgical or treatment-induced menopause, in women with breast cancer who are under treatment with an aromatase inhibitor.

Condition or disease Intervention/treatment Phase Vaginal Atrophy in Breast Cancer PatientsDrug: PlaceboDrug: Prasterone (DHEA)Phase 3


Study Design

Go to sections

Study Type :Interventional (Clinical Trial)Estimated Enrollment :500 participantsAllocation:RandomizedIntervention Model:Parallel AssignmentMasking:Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)Primary Purpose:TreatmentOfficial Title:Effect of Intravaginal Prasterone (DHEA) on Moderate to Severe Symptoms of Vulvovaginal Atrophy Due to Menopause, in Women Under Treatment With an Aromatase Inhibitor for Breast Cancer - (Placebo-Controlled, Double Blind and Randomized Phase III Study)Estimated Study Start Date :December 2018Estimated Primary Completion Date :March 2021Estimated Study Completion Date :June 2021

Resource links provided by the National Library of Medicine

Page 9 of 9 (246 results)